Amiloride lowers arterial pressure in cyp1a1ren-2 transgenic rats without affecting renal vascular function

Journal of Hypertension

Volumn 28, Issue 11, 2010, Pages 2267-2277

  Schlüter, Torsten ^a   Rohsius, Robert ^a   Wanka, Heike ^a   Schmid, Catherina ^a   Siepelmeyer, Anja ^a   Rettig, Rainer ^a   Peters, Jörg ^a   Grisk, Olaf ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

amiloride; epithelial sodium channel; kidney; renin angiotensin aldosterone system; sodium chloride homeostasis; vascular function

Indexed keywords

ACETYLCHOLINE; ALDOSTERONE; AMILORIDE; EPITHELIAL SODIUM CHANNEL; LOSARTAN; MESSENGER RNA; PHENYLEPHRINE; RENIN; SODIUM; SPIRONOLACTONE;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY COMPLIANCE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; GENE INDUCTION; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY ARTERY; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY VASCULAR RESISTANCE; MYOGRAPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM BALANCE; SODIUM EXCRETION; TELEMETRY; TRANSGENE; URINARY EXCRETION;

EID: 77958472316     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833d77b4     Document Type: Article

References (34)

1. Bhalla V, Hallows KR. Mechanisms of ENaC regulation and clinical implications. J Am Soc Nephrol 2008; 19:1845-1854.
2. Oberleithner H. Is the vascular endothelium under the control of aldosterone? Facts and hypothesis. Pflugers Arch Eur J Physiol 2007; 454:187-193.
3. Guan Z, Pollock JS, Cook AK, Hobbs JL, Inscho EW. Effect of epithelial sodium channel blockade on the myogenic response of rat juxtamedullary afferent arterioles. Hypertension 2009; 54:1062-1069.
4. Jernigan NL, Drummond HA. Myogenic vasoconstriction in mouse renal interlobar arteries: role of endogenous beta and gammaENaC. Am J Physiol Renal Physiol 2006; 291:F1184-F1191.
5. Jernigan NL, LaMarca B, Speed J, Galmiche L, Granger JP, Drummond HA. Dietary salt enhances benzamil-sensitive component of myogenic constriction in mesenteric arteries. Am J Physiol Heart Circ Physiol 2008; 294:H409-H420.
6. Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, De Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci \USA 2007; 104:16281-16286.
7. Wildling L, Hinterdorfer P, Kusche-Vihrog K, Treffner Y, Oberleithner H. Aldosterone receptor sites on plasma membrane of human vascular endothelium detected by a mechanical nanosensor. Pflugers ArchEur J Physiol 2009; 458:223-230.
8. \+ on the rat afferent arteriole and its myogenic response. Am J Physiol Renal Physiol 2008; 295:F272-F282.
9. Drummond HA, Grifoni SC, Jernigan NL. A new trick for an old dogma: ENaC proteins as mechanotransducers in vascular smooth muscle. Physiology 2008; 23:23-31.
10. Ponnuchamy B, Khalil RA. Cellular mediators of renal vascular dysfunction in hypertension. Am J Physiol Regul Integr Comp Physiol 2009; 296:R1001-R1018.
11. Rettig R, Grisk O. The kidney as a determinant of genetic hypertension: evidence from renal transplantation studies. Hypertension 2005; 46:463-468.
12. Kantachuvesiri S, Fleming S, Peters J, Peters B, Brooker G, Lammie AG, et al. Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. J Biol Chem 2001; 276:36727-36733.
13. Peters B, Grisk O, Becher B, Wanka H, Kuttler B, Ludemann J, et al. Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis. J Hypertens 2008; 26:102-109.
14. Mitchell KD, Bagatell SJ, Miller CS, Mouton CR, Seth DM, Mullins JJ. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats. J Renin Angiotensin Aldosterone Syst 2006; 7:74-86.
15. Erbanova M, Thumova M, Huskova Z, Vaneckova I, Vanourkova Z, Mullins JJ, et al. Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats. J Hypertens 2009; 27:575-586.
16. Schluter T, Grimm R, Steinbach A, Lorenz G, Rettig R, Grisk O. Neonatal sympathectomy reduces NADPH oxidase activity and vascular resistance in spontaneously hypertensive rat kidneys.AmJPhysiol Regul Integr Comp Physiol 2006; 291:R391-R399.
17. GriskO,LotherU,GabrielsG,RettigR.Influenceofneonatalsympathectomy on proximal renal resistance artery function in spontaneously hypertensive rats. Pflugers Arch Eur J Physiol 2005; 449:364-371.
18. Freslon JL, Giudicelli JF. Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharmacol 1983; 80:533-543.
19. Nyborg NC, Baandrup U, Mikkelsen EO, Mulvany MJ. Active, passive and myogenic characteristics of isolated rat intramural coronary resistance arteries. Pflugers Arch Eur J Physiol 1987; 410:664-670.
20. Peters J, Münter K, Bader M, Hackenthal E, Mullins JJ, Ganten D. Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium. J Clin Invest 1993; 91:742-747.
21. Schluter T, Zimmermann U, Protzel C, Miehe B, Klebingat K-J, Rettig R, Grisk O. Intrarenal artery superoxide is mainly NADPH oxidase-derived and modulates endothelium-dependent dilation in elderly patients. Cardiovasc Res 2010; 85:814-824.
22. Schluter T, Steinbach AC, Steffen A, Rettig R, Grisk O. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition. Cardiovasc Res 2008; 80:271-279.
23. Ortiz RM, Graciano ML, Mullins JJ, Mitchell KD. Aldosterone receptor antagonism alleviates proteinuria, but not malignant hypertension, inCyp1a1-Ren2 transgenic rats. Am J Physiol Renal Physiol 2007; 293:F1584-F1591.
24. Beutler KT, Masilamani S, Turban S, Nielsen J, Brooks HL, Ageloff S, et al. Long-term regulation of ENaC expression in kidney by angiotensin II. Hypertension 2003; 41:1143-1150.
25. Peti-Peterdi J, Warnock DG, Bell PD. Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol 2002; 13:1131-1135.
26. Ardanaz N, Pagano PJ. Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Exp Biol Med 2006; 231:237-251.
27. Gao Y-J, Lee RMKW. Hydrogen peroxide is an endothelium-dependent contracting factor in rat renal artery.Br J Pharmacol 2005; 146:1061-1068.
28. Griendling KK, Ushio-Fukai M, Lassegue B, Alexander RW. Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 1997; 29:366-373.
29. Mazak I, Fiebeler A, Muller DN, Park JK, Shagdarsuren E, Lindschau C, et al. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 2004; 109:2792-2800.
30. Mount DB, Yu ASL. Transport of inorganic solutes: sodium chloride, potassium, magnesium, calcium, and phosphate. In: Brenner BM, editor. The kidney. Philadelphia: Saunders Elsevier; 2008. pp. 156-213.
31. Ballew JR, Fink GD. Characterization of the antihypertensive effect of a thiazide diuretic in angiotensin II-induced hypertension. J Hypertens 2001; 19:1601-1606.
32. Ji Y, Huang Y, Han Y, Xu Y, Ferro A. Cardiac effects of amiloride and of enalapril in the spontaneously hypertensive rat. J Hypertens 2003; 21:1583-1589.
33. Guyton AC, Hall JE, Coleman TG, Manning RD, Norman RA. The dominant role of the kidneys in long-term arterial pressure regulation in normal and hypertensive states. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press; 1995. pp. 1311-1326.
34. Amin MS, Wang HW, Reza E, Whitman SC, Tuana BS, Leenen FH. Distribution of epithelial sodium channels and mineralocorticoid receptors in cardiovascular regulatory centers in rat brain. Am J Physiol Regul Integr Comp Physiol 2005; 289:R1787-R1797.